MoneyWorks4Me

Valiant Laboratories - Quaterly Results

14 May 2024 Evaluate
A decrease of about -65.99% in the sales to Rs. 305.83 millions was observed for the quarter ended March 2024. The sales stood at Rs. 899.19 millions during the similar quarter previous year.The Net Loss for the quarter ended March 2024 is Rs. -12.18 millions as compared to Net Profit of Rs. 78.28 millions of corresponding quarter ended March 2023Operating profit Margin for the quarter ended March 2024 slipped to -20.27% as compared to 103.36% of corresponding quarter ended March 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 305.83 899.19 -65.99 1820.52 3339.10 -45.48 1820.52 3339.10 -45.48
Other Income 25.03 17.22 45.35 96.82 48.63 99.10 96.82 48.63 99.10
PBIDT -20.27 103.36 -119.61 12.73 399.54 -96.81 12.73 399.54 -96.81
Interest 0.21 0.27 -22.22 0.78 2.54 -69.29 0.78 2.54 -69.29
PBDT -20.48 103.09 -119.87 11.95 397.00 -96.99 11.95 397.00 -96.99
Depreciation 5.02 4.40 14.09 19.48 15.63 24.63 19.48 15.63 24.63
PBT -25.50 98.69 -125.84 -7.53 381.37 -101.97 -7.53 381.37 -101.97
TAX -13.32 20.41 -165.26 -10.93 91.38 -111.96 -10.93 91.38 -111.96
Deferred Tax 2.46 -1.89 -230.16 -1.11 3.38 -132.84 -1.11 3.38 -132.84
PAT -12.18 78.28 -115.56 3.40 289.99 -98.83 3.40 289.99 -98.83
Equity 434.50 325.60 33.45 434.50 325.60 33.45 434.50 325.60 33.45
PBIDTM(%) -6.63 11.49 -157.66 0.70 11.97 -94.16 0.70 11.97 -94.16
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..